Immunology Breakfast Briefing 2024
Published on June 11, 2025.
Updated on February 03, 2026.
Briefing
Hosted
Topic
Lifting the Initial Hospital Prescription.
About
The aim of this morning session is to discuss the modification of the conditions for prescribing and dispensing (CPD) of subcutaneous biotherapies, decided by the ANSM (French National Agency for Medicinal Products) in order to allow their initiation by a specialist doctor.
Depending on the drug, and in line with current CPDs, specialists in the pathologies concerned (dermatology, rheumatology, gastroenterology, allergology and pneumology) will therefore be able to initiate these treatments in towns and cities.
